Abstract
The polymorphic enzyme human serum paraoxonase 1 (PON1), encoded by the gene PON1 (chromosome 7q21.3) plays a role as an antioxidant molecule through several mechanisms. Because oxidative stress has been implicated in the pathogenesis of migraine, we have investigated the possible association between the nonsynonymous polymorphisms 55LM and 192QR in the PON1 and the risk for migraine. We studied the frequency of the PON1 genotypes and allelic variants in 197 patients with migraine and 220 healthy controls using a TaqMan single nucleotide polymorphism analysis. The frequencies of the PON1 genotypes and PON1 allelic variants did not differ significantly between patients with migraine and controls, and were unrelated with gender, family history of migraine, and presence or absence of aura. The frequencies of the genotype PON1 192QQ and the allelic variant PON1 192Q were significantly higher in patients with earlier onset of migraine. The results of the present study suggest that PON1 polymorphisms are not related with the risk for migraine in Caucasian Spanish people, although PON1 192Q/Q genotype and PON1 192Q allelic variant should be related with an earlier onset of migraine.
Similar content being viewed by others
References
Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598–608
Boćkowski L, Sobaniec W, Kułak W, Smigielska-Kuzia J (2008) Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 60:542–548
Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23:39–42
Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2004) Flunarizine effects on oxidative stress in migraine patients. Cephalalgia 4:28–32
Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A (2007) Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 27:1136–1141
Cowan J, Sinton CM, Varley AW, Wians FH, Haley RW, Munford RS (2001) Gene therapy to prevent organophosphate intoxication. Toxicol Appl Pharmacol 173:1–6
De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L et al (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196
Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S et al (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371–377
Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn, Cephalalgia, vol 24 Suppl 1, pp 1–160
Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73–76
Kucukali CI, Aydin M, Ozkok E, Orhan N, Cakir U, Kilic G et al (2008) Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population. Psychiatr Genet 18:289–294
La Du BN (1992) Human serum paraoxonase/arylesterase. In: Kalow W (ed) Pharmacogenetics of drugs metabolism. Pergamon Press, New York, pp 51–91
Li HL, Liu DP, Liang CC (2003) Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 81:766–779
Mackness B, Durrington PN, Mackness MI (2002) The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 13:357–362
Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B et al (1998) Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341–349
Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA (1986) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69–76
Ng DS, Chu T, Esposito B, Hui P, Connelly PW, Gross PL (2008) Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovasc Pathol 17:226–232
Ophoff RA, Terwint GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1Ar. Cell 87:543–552
Rasmussen BK (2006) Epidemiology of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincot Williams & Wilkins, Philadelphia, pp 235–242
Russell MD, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. BMJ 311:541–544
Shimomura T, Kowa H, Nakano T, Kitano A, Marukawa H, Urakami K, Takahashi K (1994) Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 14:215–218
Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SA, Nag D et al (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 241:37–43
Taffi R, Vignini A, Lanciotti C, Luconi R, Nanetti L, Mazzanti L et al (2005) Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia 25:353–358
Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I, Carolei A (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17:580–584
Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbiçer H (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126:92–97
Yilmaz G, Sürer H, Inan LE, Coskun O, Yücel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211:23–30
Acknowledgments
This work was supported in part by Grants FIS 05/1056, 06/1252 and RETICS RD07/0064/0016 from Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, and FUNDESALUD, Consejería de Sanidad y Consumo, Junta de Extremadura.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García-Martín, E., Martínez, C., Serrador, M. et al. Paraoxonase 1 (PON1) polymorphisms and risk for migraine. J Neurol 257, 1482–1485 (2010). https://doi.org/10.1007/s00415-010-5551-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5551-2